Antimicrobial chemotherapy
著者
書誌事項
Antimicrobial chemotherapy
Oxford University Press, 2012
6th ed
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Antimicrobial agents are essential for the treatment of life-threatening infections and for managing the burden of minor infections in the community. In addition, they play a key role in organ and bone marrow transplantation, cancer chemotherapy, artificial joint and heart valve surgery. Unlike other classes of medicines, they are vulnerable to resistance from mutations in target microorganisms, and their adverse effects may extend to other patients (increased risk of cross-infection). As a consequence, there is a constant requirement for new agents, as well as practices that ensure the continued effective prescribing of licensed agents. Public awareness and concerns about drug resistant organisms has led to widespread publicity and political action in the UK, Europe and worldwide. The control of drug resistance and the implementation of good prescribing practice are now legal requirements in the UK as a result of the UK Health Act (2008). These fundamental changes underscore the need for a thorough understanding of the advantages and risks associated with specific antibiotic choices.
This sixth edition of Antimicrobial Chemotherapy continues to be a valuable resource for undergraduates and graduates requiring a thorough grounding in the scientific basis and clinical application of these drugs. This new edition is updated to include the most recently licensed agents, notably in the treatment of viral infections including HIV/AIDS, and contains new guidance on prescribing practice and infection control practices that limit the development and spread of resistant organisms.
目次
- Historical Introduction
- Preface
- PART ONE - ANTIMICROBIAL CHEMOTHERAPY - THE AGENTS AND THEIR GENERAL PROPERTIES
- 1. Inhibitors of bacterial cell wall synthesis
- 2. Inhibitors of bacterial protein synthesis
- 3. Synthetic antibacterial agents and miscellaneous antibiotics
- 4. Antivirals - an introduction
- 5. Antiviral drugs
- 6. Anti-HIV Agents
- 7. Antifungal agents
- 8. Antiprotozoal and anthelminthic agents
- PART TWO - ANTIMICROBIAL CHEMOTHERAPY - DRUG RESISTANCE, IMPACT AND CONTROL
- 9. The problem of resistance
- 10. The genetics and mechanisms of acquired resistance
- 11. Control of the spread of resistance
- PART THREE - ANTIMICROBIAL CHEMOTHERAPY - THE SCIENCE AND PRACTICE OF USE
- 12. Laboratory investigations and the treatment of infection
- 13. General principles of the treatment of infection
- 14. Pharmacokinetic and pharmacodynamic principles
- 15. Prescribing in children and the elderly
- 16. Outpatient Parenteral Antibiotic Prescribing
- 17. Adverse drug reactions
- 18. Preventing infection - chemoprophylaxis and immunoprophylaxis (immunisation schedule)
- 19. Guidelines, formularies and antimicrobial policies
- 20. Antimicrobial stewardship and the multi-professional antimicrobial management team
- PART FOUR - ANTIMICROBIAL CHEMOTHERAPY - THEIR THERAPEUTIC USE
- 21. Respiratory tract infections
- 22. Topical use of antimicrobial agents
- 23. Urinary tract infections
- 24. Sexually transmitted infections
- 25. Gastrointestinal infections
- 26. Serious blood stream infections
- 27. Infections of the bones and joints
- 28. Infections of the central nervous system
- 29. Infections of the skin and soft tissues
- 30. Tuberculosis and other mycobacterial diseases
- 31. Infections in the immunocompromised patient including HIV/AIDS
- 32. Viral infections
- 33. HIV infections
- 34. Viral hepatitis
- 35. Parasitic diseases
- 36. ostscript: the development and marketing of antimicrobial drugs
「Nielsen BookData」 より